The prescribing cascade

Australian Prescriber

Volumn 34, Issue 6, 2011, Pages 162-166

  Kalisch, Lisa M ^a   Caughey, Gillian E ^a   Roughead, Elizabeth E ^a   Gilbert, Andrew L ^a  

^a UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

Adverse effects; Polypharmacy

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTIHYPERTENSIVE AGENT; BENZODIAZEPINE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM CHANNEL BLOCKING AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; CODEINE; CORTICOSTEROID; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ERYTHROMYCIN; HALOPERIDOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC AGENT; LOOP DIURETIC AGENT; METOCLOPRAMIDE; NEUROLEPTIC AGENT; NITRATE; NONSTEROID ANTIINFLAMMATORY AGENT; OPIATE; PAROXETINE; PROCHLORPERAZINE; SEDATIVE AGENT; THIAZIDE DIURETIC AGENT; UNINDEXED DRUG; VASODILATOR AGENT;

ADVERSE OUTCOME; ARTICLE; AWARENESS; CLOSTRIDIUM DIFFICILE INFECTION; COUGHING; DISEASE SEVERITY; DIZZINESS; GOUT; HEALTH CARE SYSTEM; HEART ARRHYTHMIA; HUMAN; HYPERTENSION; HYPERURICEMIA; INCONTINENCE; MORBIDITY; MORTALITY; MOTOR DYSFUNCTION; NAUSEA; ORTHOSTATIC HYPOTENSION; OSTEOPOROSIS; PRESCRIPTION; RASH; RECOGNITION; TREMOR;

EID: 82855161596     PISSN: 03128008     EISSN: None     Source Type: Journal    
DOI: 10.18773/austprescr.2011.084     Document Type: Article

References (23)

1. Miller GC, Britth HC, Valenti L. Adverse drug events in general practice patients in Australia. Med J Aust 2006;184:321-4.
2. Miller GC, Britt HC, Valenti L, Knox S. Adverse drug events: counting is not enough, action is needed [editorial]. Med J Aust 2006;184:646.
3. Roughead EE, Semple SJ. Medication safety in acute care in Australia: where are we now? Part 1: a review of the extent and causes of medication problems 2002-2008. Aust New Zealand Health Policy 2009;6:18.
4. Rochon PA, Gurwitz JH. Optimising drug treatment for elderly people: the prescribing cascade. BMJ 1997;315:1096-9.
5. Caughey GE, Roughead EE, Pratt N, Shakib S, Vitry AI, Gilbert AL. Increased risk of hip fracture in the elderly associated with prochlorperazine: is a prescribing cascade contributing? Pharmacoepidemiol Drug Saf 2010;19:977-82.
6. Bentler SE, Liu L, Obrizan M, Cook EA, Wright KB, Geweke JF, et al. The aftermath of hip fracture: discharge placement, functional status change, and mortality. Am J Epidemiol 2009;170:1290-9.
7. Liu PT, Argento VS, Skudlarska BA. Prescribing cascade in an 80-year-old Japanese immigrant. Geriatr Gerontol Int 2009;9:402-4.
8. Burgess CL, Holman CD, Satti AG. Adverse drug reactions in older Australians, 1981-2002. Med J Aust 2005;182:267-70.
9. Easton K, Morgan T, Williamson M. Medication safety in the community: a review of the literature. Sydney: National Prescribing Service; 2009. www.nps.org.au/research_and_evaluation/current_research/medication_safety_community [cited 2011 Nov 7]
10. Colebatch KA, Marley J, Doecke C, Miles H, Gilbert A. Evaluation of a patient event report monitoring system. Pharmacoepidemiol Drug Saf 2000;9:491-9.
11. Routledge PA, O'Mahony MS, Woodhouse KW. Adverse drug reactions in elderly patients. Br J Clin Pharmacol 2004;57:121-6.
12. Blendon RJ, Schoen C, DesRoches C, Osborn R, Zapert K. Common concerns amid diverse systems: Health care experiences in five countries. Health Aff (Millwood) 2003;22:106-21.
13. Schoen C, Osborn R, Huynh PT, Doty M, Davis K, Zapert K, et al. Primary care and health system performance: Adults' experiences in five countries. Health Aff 2004;Suppl web exclusives:W4-487-503.
14. Gilbert AL, Roughead EE, Beilby J, Mott K, Barratt JD. Collaborative medication management services: improving patient care. Med J Aust 2002;177:189-92.
15. Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, et al. The effectiveness of collaborative medicine reviews in delaying time to next hospitalisation for patients with heart failure in the practice setting: results of a cohort study. Circ Heart Fail 2009;2:424-8.
16. Roughead EE, Barratt JD, Ramsay E, Pratt N, Ryan P, Peck R, et al. Collaborative home medicines review delays time to next hospitalization for warfarin associated bleeding in Australian war veterans. J Clin Pharm Ther 2011;36:27-32.
17. Gill SS, Mamdani M, Naglie G, Streiner DL, Bronskill SE, Kopp A, et al. A prescribing cascade involving cholinesterase inhibitors and anticholinergic drugs. Arch Intern Med 2005;165:808-13.
18. Vegter S, de Jong-van den Berg LT. Misdiagnosis and mistreatment of a common side-effect-angiotensin-converting enzyme inhibitor-induced cough. Br J Clin Pharmacol 2010;69:200-3.
19. Mallet L, Spinewine A, Huang A. The challenge of managing drug interactions in elderly people. Lancet 2007;370:185-91.
20. Corrao G, Botteri E, Bagnardi V, Zambon A, Carobbio A, Falcone C, et al. Generating signals of drug-adverse effects from prescription databases and application to the risk of arrhythmia associated with antibacterials. Pharmacoepidemiol Drug Saf 2005;14:31-40.
21. Tsiropoulos I, Andersen M, Hallas J. Adverse events with use of antiepileptic drugs: a prescription and event symmetry analysis. Pharmacoepidemiol Drug Saf 2009;18:483-91.
22. Bytzer P, Hallas J. Drug-induced symptoms of functional dyspepsia and nausea. A symmetry analysis of one million prescriptions. Aliment Pharmacol Ther 2000;14:1479-84.
23. Rochon PA, Gurwitz JH. Drug therapy. Lancet 1995;346:32-6.